Navigation Links
Northfield Automation Announces Wholly Owned Subsidiary to Diversify Into Medical Device Market
Date:2/14/2008

Northfield Medimation offers FDA validation designed into advanced

automation processes

NORTHFIELD, Minn., Feb. 14 /PRNewswire/ -- Northfield Automation, a leader in roll-to-roll process equipment for thin-material handling applications, announces the formation of Northfield Medimation, a wholly owned subsidiary that will diversify the company into the medical device market. The subsidiary provides advanced automation and robotics for applications such as cardio-vascular devices and fabrication of transdermal patches, test strips and related diagnostic materials.

The company also announces the appointment of Jahn Stopperan as the subsidiary's general manager. Formerly principal of Technasport, a new product development company, Stopperan brings more than 20 years of experience in business management, marketing, sales, and product development to his new role at Northfield Medimation.

"The medical device industry is a stable market with many new opportunities for automation that can benefit by having FDA validation completed by the equipment provider," according to Brett Reese, chairman and chief executive officer of Northfield Automation. "In addition to medical, we are diversifying into the thin solar cell, electronic display and flexible battery industries to help us reach our growth goals of 25 percent per year," he says.

Customization, reliability and validation are Northfield Medimation's competitive advantages based on its design-intensive focus and engineering expertise of its parent company.

Customized automation solutions are engineered to meet complex medical manufacturing requirements for single machines or integrated systems. Many applications are automated to reduce process variability, limit risk and reduce manual content.

Complete validation services include documentation materials designed to meet each customer's specifications and regulatory requirements. By outsourcing t
'/>"/>

SOURCE Northfield Automation Systems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Brooks Automation Executive and Board Member Should Use Sarbanes-Oxley Disclosure Rules in Non-Profit Role, Asserts 1199 SEIU
2. IH Systems Announces $7.6 million in Financing to Advance RIVA Pharmacy Automation System
3. Axeda Selected for Remote Monitoring and Service of Automation Technologies
4. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
5. NBTY Announces Preliminary Unaudited Net Sales Results for January 2008
6. Genoptix Announces Filing of Registration Statement for Secondary Public Offering of Common Stock
7. Vical Announces News Release and Conference Call Schedule for 2007 Financial Results
8. Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
9. ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006
10. NightHawk Radiology Holdings, Inc. Announces Fourth Quarter and Full-Year 2007 Results; Updates 2008 Guidance
11. Watson Pharmaceuticals Announces FDA Inspection of Florida Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...8 /PRNewswire-FirstCall/ - Med-Emerg International...eading providers of health services, is pleased to...ur of the previously announced plan of arrangement...AIM") at a special meeting of MedEmerg,s sharehold... votes cast at the meeting were in favour of the A...
(Date:1/8/2009)...., Jan. 8 Today, the Na...ong with several national leadership organizations...ples of hospice care and protection of the Medicar...ther in sharing this unified message about end-of-...and Palliative Medicine, Hospice and Palliative Nu...
(Date:1/8/2009)...embly Member Tom Torlakson Introduces AB 89 , ,.../ -- Today, Lung Cancer Alliance-California (LCA...son (D-11th District) for his continued leadership...lung cancer research. For the third consecutive y...rch is being considered in the California Legislat...
(Date:1/8/2009)...ered bad cholesterol more effectively than Zocor ,...After nearly a year of review, U.S. health officia... use of the controversial cholesterol-lowering dru...ion said there was no significant difference in ca...orin and patients taking the drug Zocor. , But,...
Breaking Medicine News(10 mins):Health News:Shareholders of Med-Emerg International Inc. approve plan of arrangement with AIM Health Group Inc. 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Lung Cancer Alliance Applauds New Legislation Funding Lung Cancer Research 2Health News:FDA Backs Cholesterol Drug Vytorin 2
...e National Health Services (NHS) patients, current...ttended to following the Government report that wo...ials had stated earlier that the maximum waiting p... they were to be admitted to a hospital by the end...
...nada: There is good news for patients afflicted b...aster, bone marrow donees and several others who a...e, invented by a researcher // at the University o...BR), is capable of scaling down the loss of transf...
...cording to scientist a new computer model has been...pidemic of malaria. The intensity whether it would...it occurs. // This would give ample time for preve...one in advance. The control of malaria is a top p...
...ientists in northern Tasmania have revealed that t...ng tumor disease affecting Tasmanian devils. // Th...also be transferred when the animals are mating, t...nne-Maree Pearse from the state's Primary Industri...
Other Medicine News:Health News:Quality Platelets and Improved Blood Availability No Longer a Pipe Dream 2Health News:Prediction of malaria epidemics possible! 2
(Date:1/8/2009)..., UT Southwestern to Identify and Validate Novel...ing with Innovative Gene Expression Platform , ,...- WaferGen Biosystems, Inc. (OTC Bulletin Board: W... expression, genotyping, cell biology and stem cel... a research collaboration with the University of ...
(Date:1/7/2009)..., INDIANAPOLIS, Jan. 7 /PRNewswire-FirstCall...ed today that it received a complete response lett...A) for olanzapine long-acting,injection (LAI) for...in,adults. Lilly is continuing to work with the a... The FDA does not require any additional clinical ...
(Date:1/7/2009)..., First of Several Products in Development Based...ogy to Stimulate Natural BioRegeneration; FDA Fili...TOWN, N.J., Jan. 7 Ost...erging field of biologic products for regenerative...pivotal clinical trial for its DuraTech(TM) BioReg...
(Date:1/6/2009)..., Proves significance of AHCC for maintaining a ...6 A recently published study in N...rs at Kansai Medical University in Osaka, Japan ha...nd) enhances immune function by increasing the num...f the immune system responsible for presenting for...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 2FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 3FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 4FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 5FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Online Counseling and Life Coaching Practice Launches New Website 24418 1Online Counseling and Life Coaching Practice Launches New Website 24418 2NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 1NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 2NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 3NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 4NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 5NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 6NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 7NYU Langone Medical Centers tip sheet to the International Conference on Alzheimers Disease 2008 4210 8BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 1BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 2BioTrends Releases Quarterly TreatmentTrends 28TM 29 3A Nephrology Report Highlighting Market Trends for Renal Anemia Hyperphosphatemia and Secondar 6748 3Experts to provide peek of Smithsonian soils exhibit 4208 1
... of cancer returning,after surgery for Kit-positiv...OVER, N.J., April 12, 2007 /PRNewswire/ -- Investi...sylate)* tablets to,patients receiving placebo in ...erim analysis showed participants with Kit-positiv...evec following,surgery were significantly less lik...
...,/PRNewswire-FirstCall/ -- Data analyses from the ...m ever undertaken in the renal,anemia arena provid...tional anemia therapy MIRCERA(TM) for the treatmen...isease (CKD) in,patients on dialysis and not on di...National Kidney Foundation 2007 Spring Clinical,Me...
Other Medicine Technology:Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4
... knee prosthesis stems from many years of experien... and manufacturing technologies have been used in ... well as a favorable pressure distribution pattern... a minimum. The inherent design of the components,...
... "Consensus Concept" approach to design by combini...perience of a Scientific Advisory Board. The resul...tate-of-the-art features. Consensus Knee implants ...bility and allow near normal kinematics. The compo...
The major innovations in posterior stabilized (PS) knee design.
The GENESIS II* Total Knee System will define the state of knee implants.
Medicine Products: